| Showcasing Digital Innovation at Korea’s Largest Medical Device Exhibition, Reinforcing Global Leadership in Bio-Pharma
| Well-Received Practical Solutions for Streamlining Global Regulatory Approvals, Backed by Expert-Led Consultations
| AWS-Powered Digital Solutions Set a New Standard in Clinical and Medical Data Management, Capturing Industry Attention
| Driving Global Competitiveness with Comprehensive Services—From International Regulatory & Clinical Consulting to Cutting-Edge Cloud Technologies
JNPMEDI has further solidified its reputation as a leading global bio-pharma innovation partner through its successful participation in KIMES 2025.
The clinical trial consulting and platform company, JNPMEDI announced on the 24th that it had successfully wrapped up its exhibition at the 40th Korea International Medical & Hospital Equipment Show (KIMES 2025), held at COEX, Seoul, from March 20th to 23rd. Through this event, JNPMEDI reinforced its collaboration with pharmaceutical and biotechnology companies worldwide.
At KIMES 2025, JNPMEDI showcased its expertise in medical device clinical operations and cloud-based clinical and medical data management strategies, drawing strong interest from industry professionals. The company also provided tailored one-on-one consulting sessions for pre-registered companies, offering practical solutions to streamline global regulatory approval processes. These expert-led consultations were highly praised for their depth and precision, further enhancing their value for attendees.
Another highlight was JNPMEDI’s AWS-powered clinical and medical data management solutions, which offer a secure, cost-effective approach to clinical research. By leveraging AWS cloud infrastructure, these solutions enable companies to reduce initial infrastructure costs while ensuring more structured and efficient clinical trial operations.
As this was JNPMEDI’s first major showcase since becoming an AWS-certified Managed Service Provider (MSP), the event also spotlighted optimized cloud resource management, enhanced security protocols, and scalable infrastructure solutions tailored to research needs. The advanced digital solutions gained significant attention from industry stakeholders.
“KIMES 2025 provided a valuable opportunity to showcase our expertise in medical device clinical trials and global regulatory consulting while introducing a new standard for clinical and medical data management through AWS cloud technology,” said KwunHo Jeong, CEO of JNPMEDI. “Moving forward, we aim to expand our collaborations with medical device companies worldwide, further strengthening our competitive edge in the global market.”
Building on the networks and feedback gathered at KIMES 2025, JNPMEDI plans to further refine its global regulatory and clinical consulting services. The company will also actively leverage AWS technology to develop customized solutions that support medical device companies in their global market expansion while continuing to broaden its strategic collaborations.
| Showcasing Digital Innovation at Korea’s Largest Medical Device Exhibition, Reinforcing Global Leadership in Bio-Pharma
| Well-Received Practical Solutions for Streamlining Global Regulatory Approvals, Backed by Expert-Led Consultations
| AWS-Powered Digital Solutions Set a New Standard in Clinical and Medical Data Management, Capturing Industry Attention
| Driving Global Competitiveness with Comprehensive Services—From International Regulatory & Clinical Consulting to Cutting-Edge Cloud Technologies
JNPMEDI has further solidified its reputation as a leading global bio-pharma innovation partner through its successful participation in KIMES 2025.
The clinical trial consulting and platform company, JNPMEDI announced on the 24th that it had successfully wrapped up its exhibition at the 40th Korea International Medical & Hospital Equipment Show (KIMES 2025), held at COEX, Seoul, from March 20th to 23rd. Through this event, JNPMEDI reinforced its collaboration with pharmaceutical and biotechnology companies worldwide.
At KIMES 2025, JNPMEDI showcased its expertise in medical device clinical operations and cloud-based clinical and medical data management strategies, drawing strong interest from industry professionals. The company also provided tailored one-on-one consulting sessions for pre-registered companies, offering practical solutions to streamline global regulatory approval processes. These expert-led consultations were highly praised for their depth and precision, further enhancing their value for attendees.
Another highlight was JNPMEDI’s AWS-powered clinical and medical data management solutions, which offer a secure, cost-effective approach to clinical research. By leveraging AWS cloud infrastructure, these solutions enable companies to reduce initial infrastructure costs while ensuring more structured and efficient clinical trial operations.
As this was JNPMEDI’s first major showcase since becoming an AWS-certified Managed Service Provider (MSP), the event also spotlighted optimized cloud resource management, enhanced security protocols, and scalable infrastructure solutions tailored to research needs. The advanced digital solutions gained significant attention from industry stakeholders.
“KIMES 2025 provided a valuable opportunity to showcase our expertise in medical device clinical trials and global regulatory consulting while introducing a new standard for clinical and medical data management through AWS cloud technology,” said KwunHo Jeong, CEO of JNPMEDI. “Moving forward, we aim to expand our collaborations with medical device companies worldwide, further strengthening our competitive edge in the global market.”
Building on the networks and feedback gathered at KIMES 2025, JNPMEDI plans to further refine its global regulatory and clinical consulting services. The company will also actively leverage AWS technology to develop customized solutions that support medical device companies in their global market expansion while continuing to broaden its strategic collaborations.